241 related articles for article (PubMed ID: 19699300)
1. LRP1 regulates remodeling of the extracellular matrix by fibroblasts.
Gaultier A; Hollister M; Reynolds I; Hsieh EH; Gonias SL
Matrix Biol; 2010 Jan; 29(1):22-30. PubMed ID: 19699300
[TBL] [Abstract][Full Text] [Related]
2. Urokinase-type Plasminogen Activator (uPA) Binding to the uPA Receptor (uPAR) Promotes Axonal Regeneration in the Central Nervous System.
Merino P; Diaz A; Jeanneret V; Wu F; Torre E; Cheng L; Yepes M
J Biol Chem; 2017 Feb; 292(7):2741-2753. PubMed ID: 27986809
[TBL] [Abstract][Full Text] [Related]
3. A Cross Talk between Neuronal Urokinase-type Plasminogen Activator (uPA) and Astrocytic uPA Receptor (uPAR) Promotes Astrocytic Activation and Synaptic Recovery in the Ischemic Brain.
Diaz A; Merino P; Manrique LG; Ospina JP; Cheng L; Wu F; Jeanneret V; Yepes M
J Neurosci; 2017 Oct; 37(43):10310-10322. PubMed ID: 28931568
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the urokinase receptor (uPAR) by LDL receptor-related protein-1 (LRP1).
Gonias SL; Gaultier A; Jo M
Curr Pharm Des; 2011; 17(19):1962-9. PubMed ID: 21711236
[TBL] [Abstract][Full Text] [Related]
5. The receptor for urokinase-type plasminogen activator regulates fibronectin matrix assembly in human skin fibroblasts.
Monaghan E; Gueorguiev V; Wilkins-Port C; McKeown-Longo PJ
J Biol Chem; 2004 Jan; 279(2):1400-7. PubMed ID: 14602715
[TBL] [Abstract][Full Text] [Related]
6. Membrane type-1 matrix metalloproteinase activity is regulated by the endocytic collagen receptor Endo180.
Messaritou G; East L; Roghi C; Isacke CM; Yarwood H
J Cell Sci; 2009 Nov; 122(Pt 22):4042-8. PubMed ID: 19861500
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stromal cells enhance self-assembly of a HUVEC tubular network through uPA-uPAR/VEGFR2/integrin/NOTCH crosstalk.
Beloglazova I; Stepanova V; Zubkova E; Dergilev K; Koptelova N; Tyurin-Kuzmin PA; Dyikanov D; Plekhanova O; Cines DB; Mazar AP; Parfyonova Y
Biochim Biophys Acta Mol Cell Res; 2022 Jan; 1869(1):119157. PubMed ID: 34619163
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins.
Czekay RP; Aertgeerts K; Curriden SA; Loskutoff DJ
J Cell Biol; 2003 Mar; 160(5):781-91. PubMed ID: 12615913
[TBL] [Abstract][Full Text] [Related]
9. Urokinase-type plasminogen activator receptor (uPAR) ligation induces a raft-localized integrin signaling switch that mediates the hypermotile phenotype of fibrotic fibroblasts.
Grove LM; Southern BD; Jin TH; White KE; Paruchuri S; Harel E; Wei Y; Rahaman SO; Gladson CL; Ding Q; Craik CS; Chapman HA; Olman MA
J Biol Chem; 2014 May; 289(18):12791-804. PubMed ID: 24644284
[TBL] [Abstract][Full Text] [Related]
10. CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity.
Montgomery N; Hill A; McFarlane S; Neisen J; O'Grady A; Conlon S; Jirstrom K; Kay EW; Waugh DJ
Breast Cancer Res; 2012 May; 14(3):R84. PubMed ID: 22621373
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitors regulate cell adhesion through a uPAR-dependent mechanism.
Czekay RP; Loskutoff DJ
J Cell Physiol; 2009 Sep; 220(3):655-63. PubMed ID: 19472211
[TBL] [Abstract][Full Text] [Related]
12. Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis.
He Y; Liu XD; Chen ZY; Zhu J; Xiong Y; Li K; Dong JH; Li X
Clin Cancer Res; 2007 Jun; 13(11):3115-24. PubMed ID: 17545513
[TBL] [Abstract][Full Text] [Related]
13. Mitogenic signaling of urokinase receptor-deficient kidney fibroblasts: actions of an alternative urokinase receptor and LDL receptor-related protein.
Zhang G; Cai X; López-Guisa JM; Collins SJ; Eddy AA
J Am Soc Nephrol; 2004 Aug; 15(8):2090-102. PubMed ID: 15284295
[TBL] [Abstract][Full Text] [Related]
14. Urokinase-type plasminogen activator negatively regulates α-smooth muscle actin expression via Endo180 and the uPA receptor in corneal fibroblasts.
Sugioka K; Nishida T; Kodama-Takahashi A; Murakami J; Mano F; Okada K; Fukuda M; Kusaka S
Am J Physiol Cell Physiol; 2022 Jul; 323(1):C104-C115. PubMed ID: 35649252
[TBL] [Abstract][Full Text] [Related]
15. Urokinase receptor cleavage: a crucial step in fibroblast-to-myofibroblast differentiation.
Bernstein AM; Twining SS; Warejcka DJ; Tall E; Masur SK
Mol Biol Cell; 2007 Jul; 18(7):2716-27. PubMed ID: 17507651
[TBL] [Abstract][Full Text] [Related]
16. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
[TBL] [Abstract][Full Text] [Related]
17. Activated α2-macroglobulin induces Müller glial cell migration by regulating MT1-MMP activity through LRP1.
Barcelona PF; Jaldín-Fincati JR; Sánchez MC; Chiabrando GA
FASEB J; 2013 Aug; 27(8):3181-97. PubMed ID: 23640058
[TBL] [Abstract][Full Text] [Related]
18. The urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/Endo180): membrane proteins engaged in matrix turnover during tissue remodeling.
Behrendt N
Biol Chem; 2004 Feb; 385(2):103-36. PubMed ID: 15101555
[TBL] [Abstract][Full Text] [Related]
19. The mosaic receptor sorLA/LR11 binds components of the plasminogen-activating system and platelet-derived growth factor-BB similarly to LRP1 (low-density lipoprotein receptor-related protein), but mediates slow internalization of bound ligand.
Gliemann J; Hermey G; Nykjaer A; Petersen CM; Jacobsen C; Andreasen PA
Biochem J; 2004 Jul; 381(Pt 1):203-12. PubMed ID: 15053742
[TBL] [Abstract][Full Text] [Related]
20. Embryonic fibroblasts that are genetically deficient in low density lipoprotein receptor-related protein demonstrate increased activity of the urokinase receptor system and accelerated migration on vitronectin.
Weaver AM; Hussaini IM; Mazar A; Henkin J; Gonias SL
J Biol Chem; 1997 May; 272(22):14372-9. PubMed ID: 9162074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
